Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Schizophrenia

Free Subscription 27.10.2025 1 Am J Med Genet B Neuropsychiatr Genet 2 Biol Psychiatry 1 Can J Psychiatry 1 J Clin Psychiatry 1 Mol Psychiatry 1 Psychiatry Res 8 Schizophr Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Med Genet B Neuropsychiatr Genet

1. SERRETTI A, Souery D, Kasper S, Zohar J, et al
   Schizophrenia Genetics Modulates Clinical Depressive Features.
   Am J Med Genet B Neuropsychiatr Genet. 2025 Oct 20. doi: 10.1002/ajmg.b.33066.
   PubMed         Abstract available
   
   

   
   Biol Psychiatry

2. HOWES OD, Vano LJ, Petty AE, Rutigliano G, et al
   The trace amine-associated receptor 1 regulates presynaptic dopamine function: evidence from preclinical studies and a phase 1b trial in patients with schizophrenia.
   Biol Psychiatry. 2025 Oct 21:S0006-3223(25)01533.
   PubMed         Abstract available
   
   
3. MEMETOGLU O, Du F, Chouinard VA, Ongur D, et al
   Reductive Stress and Dysregulated Energy Metabolism in Schizophrenia: Mechanisms and Therapeutic Targets.
   Biol Psychiatry. 2025 Oct 16:S0006-3223(25)01528.
   PubMed         Abstract available
   
   

   
   Can J Psychiatry

4. SKIBA RM, Chinchani AM, Menon M, Lepage M, et al
   A multisite study of the overlap between symptoms and cognition in schizophrenia: Une etude multicentrique sur le chevauchement entre les symptomes et les troubles cognitifs chez les personnes atteintes de schizophrenie.
   Can J Psychiatry. 2025 Oct 22:7067437251387565. doi: 10.1177/07067437251387565.
   PubMed         Abstract available
   
   

   
   J Clin Psychiatry

5. FAN X, Freudenreich O, Jarskog LF, McEvoy J, et al
   Brexpiprazole for the Treatment of Co-occurring Schizophrenia and Substance Use Disorder: A Multisite, Randomized, Controlled Trial.
   J Clin Psychiatry. 2025;86:25m15786.
   PubMed         Abstract available
   
   

   
   Mol Psychiatry

6. LIU S, Agartz I, Allen P, Amminger GP, et al
   Structural covariance network topology in individuals at clinical high risk for psychosis: the ENIGMA-CHR Study.
   Mol Psychiatry. 2025 Oct 22. doi: 10.1038/s41380-025-03304.
   PubMed         Abstract available
   
   

   
   Psychiatry Res

7. MUELLER N, Mulfarth R, Seuffert S, Dannlowski U, et al
   Figurative language production in schizophrenia, bipolar disorder, and depression.
   Psychiatry Res. 2025;354:116772.
   PubMed         Abstract available
   
   

   
   Schizophr Res

8. XAVIER G, Ota V, Kajitani GS, Mauer JH, et al
   Dysregulation of miR-335-5p, miR-30d-5p, and miR-744-5p in extracellular vesicles from first-episode psychosis patients: Implications for biomarker discovery.
   Schizophr Res. 2025;286:74-81.
   PubMed         Abstract available
   
   
9. FABRIS D, Andrade LM, Freitas IS, Gomes FV, et al
   Cannabidiol attenuates behavioral and electrophysiological changes in the MAM model of schizophrenia in male and female rats.
   Schizophr Res. 2025;286:63-73.
   PubMed         Abstract available
   
   
10. CAMON E, Masier S, Mota NB, D'Agostino A, et al
    Machine learning and graph-based connectivity metrics identify language disruption in psychosis: Novel insights from dream reports in an Italian cohort.
    Schizophr Res. 2025;286:55-62.
    PubMed         Abstract available
    
    
11. JI T, Yu B, Ma R
    Cerebellar-cortical dysfunction and schizophrenia: Advances in neurocognition and therapeutic strategies.
    Schizophr Res. 2025;286:37-46.
    PubMed         Abstract available
    
    
12. KWOK SYCL, Li Y, Chu MH, Singh H, et al
    The effectiveness of enhanced WELLFOCUS positive psychotherapy for people with schizophrenia: A randomised controlled trial in halfway houses in Hong Kong.
    Schizophr Res. 2025;286:26-36.
    PubMed         Abstract available
    
    
13. TABATA K, Toriumi K, Suzuki K, Takagi H, et al
    Schizophrenia with hypozincemia: Clinical features and symptom severity.
    Schizophr Res. 2025;286:9-15.
    PubMed         Abstract available
    
    
14. LUTHER L, Mathis RF, Keller WR, Buchanan RW, et al
    Aberrant visual attention is associated with social judgements of attractiveness and negative symptoms in schizophrenia.
    Schizophr Res. 2025;286:1-8.
    PubMed         Abstract available
    
    
15. DENAROSO GE, Liu J, Ered A, Woodward ND, et al
    Nonlinear associations between reported childhood trauma and cognitive impairment in schizophrenia spectrum disorders.
    Schizophr Res. 2025;285:360-368.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.